Cargando…
ODP212 Inpatient Euglycemic DKA due to SGLT2 Inhibitors – Lessons From a Case Series and Strategies to Decrease Incidence
BACKGROUND: In the past decade, sodium-glucose co-transporter 2 inhibitors (SGLT2i) have revolutionized diabetes mellitus (DM) care due to reduction of major cardiovascular events, heart failure hospitalizations, renal disease progression, and all-cause mortality. SGLT2i are now recommended by the A...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628814/ http://dx.doi.org/10.1210/jendso/bvac150.664 |